Page last updated: 2024-10-19

thioctic acid and Alloxan Diabetes

thioctic acid has been researched along with Alloxan Diabetes in 149 studies

Thioctic Acid: An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.

Research Excerpts

ExcerptRelevanceReference
"Time-dependent effects of alpha-lipoic acid/nifedipine/glimepiride combination on diabetic neuropathies were investigated in rats."8.12Diurnal efficacy of alpha-lipoic acid/nifedipine/glimepiride combination mitigates diabetic neuropathies in rats. ( Anafi, SB; Bisalla, M; Olurishe, TO; Oraebosi, MI, 2022)
"Objective To observe the expression of Notch2, NLR family pyrin domain containing 3 (NLRP3) in the renal tissue of rats with diabetes mellitus (DM), and the effects of alpha-lipoamide (ALM) on the expression of Notch2, Toll-like receptor 4 (TLR4), NLRP3 and collagen, to explore the possible protective mechanism of ALM against diabetic renal inflammation and renal fibrosis."7.88[Alpha-lipoamide inhibits renal inflammation and collagen 4 production in diabetic rats and its mechanism]. ( Guo, B; Jiang, X; Mao, Y; Peng, C; Tang, L; Wang Wang, Y; Xiao, Y; Yuan, Z; Zhang, F; Zhang, Y, 2018)
"The purpose of this study was to determine whether α-lipoic acid and fisetin have protective effects against cataract in a streptozotocin-induced experimental cataract model."7.81Effects of two antioxidants; α-lipoic acid and fisetin against diabetic cataract in mice. ( Ayar, A; Çolak, R; Kan, E; Kiliçkan, E, 2015)
"The effects of 3-oxypyridine and succinic acid derivatives (emoxipine, reamberin and mexidol) on affective disorders in rats with alloxan diabetes were studied."7.81[Anxiolytic and antidepressant effects of 3-oxypiridine and succinic acid derivatives in alloxan diabetes]. ( Faizullin, RM; Kalugina, AV; Miroshnichenko, IY; Pryakhina, KE; Rassokhina, LM; Volchegorskii, LA, 2015)
"The effects of original Russian preparations, derivatives of 3-hydroxypyridine and succinic acid (emoxipin, reamberin, mexidol), on the cellular composition of the cerebrocortical and diencephalic structures were studied and correlations of shifts in the cellular composition with changes in the severity of hyperglycemia in rats with alloxan diabetes were analyzed."7.79Cerebroprotective effects of emoxipin, reamberin, and mexidol in alloxan diabetes. ( Miroshnichenko, IY; Rassokhina, LM; Volchegorskii, IA, 2013)
"Time-dependent effects of alpha-lipoic acid/nifedipine/glimepiride combination on diabetic neuropathies were investigated in rats."4.12Diurnal efficacy of alpha-lipoic acid/nifedipine/glimepiride combination mitigates diabetic neuropathies in rats. ( Anafi, SB; Bisalla, M; Olurishe, TO; Oraebosi, MI, 2022)
" The aim of this study was to evaluate the interaction of pregabalin + thioctic acid or pregabalin + α-tocopherol on allodynia and motor performance in neonatal streptozotocin-induced diabetic rats."3.88Antiallodynic interaction and motor performance of the pregabalin/thioctic acid and pregabalin/α-tocopherol combinations in neonatal streptozotocin-induced diabetic rats. ( Araiza-Saldaña, CI; Cruz-Álvarez, LE; Flores-Murrieta, FJ; Huerta-Cruz, JC; Reyes-García, JG; Rocha-González, HI; Zúñiga-Romero, Á, 2018)
"Objective To observe the expression of Notch2, NLR family pyrin domain containing 3 (NLRP3) in the renal tissue of rats with diabetes mellitus (DM), and the effects of alpha-lipoamide (ALM) on the expression of Notch2, Toll-like receptor 4 (TLR4), NLRP3 and collagen, to explore the possible protective mechanism of ALM against diabetic renal inflammation and renal fibrosis."3.88[Alpha-lipoamide inhibits renal inflammation and collagen 4 production in diabetic rats and its mechanism]. ( Guo, B; Jiang, X; Mao, Y; Peng, C; Tang, L; Wang Wang, Y; Xiao, Y; Yuan, Z; Zhang, F; Zhang, Y, 2018)
"The purpose of this study was to determine whether α-lipoic acid and fisetin have protective effects against cataract in a streptozotocin-induced experimental cataract model."3.81Effects of two antioxidants; α-lipoic acid and fisetin against diabetic cataract in mice. ( Ayar, A; Çolak, R; Kan, E; Kiliçkan, E, 2015)
"The effects of 3-oxypyridine and succinic acid derivatives (emoxipine, reamberin and mexidol) on affective disorders in rats with alloxan diabetes were studied."3.81[Anxiolytic and antidepressant effects of 3-oxypiridine and succinic acid derivatives in alloxan diabetes]. ( Faizullin, RM; Kalugina, AV; Miroshnichenko, IY; Pryakhina, KE; Rassokhina, LM; Volchegorskii, LA, 2015)
"The effects of original Russian preparations, derivatives of 3-hydroxypyridine and succinic acid (emoxipin, reamberin, mexidol), on the cellular composition of the cerebrocortical and diencephalic structures were studied and correlations of shifts in the cellular composition with changes in the severity of hyperglycemia in rats with alloxan diabetes were analyzed."3.79Cerebroprotective effects of emoxipin, reamberin, and mexidol in alloxan diabetes. ( Miroshnichenko, IY; Rassokhina, LM; Volchegorskii, IA, 2013)
" Compared with control rats, D developed increased urinary excretion of albumin and transforming growth factor beta, renal insufficiency, glomerular mesangial matrix expansion, and glomerulosclerosis in association with depletion of glutathione and accumulation of malondialdehyde in renal cortex."3.71Alpha-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes. ( Craven, PA; DeRubertis, FR; Liachenko, J; Melhem, MF, 2002)
"This study investigated the effects of trelagliptin and remogliflozin, alone and in combination with alpha lipoic acid (ALA), on cardiac biomarkers in diabetic cardiomyopathy (DCM)."1.91Impacts of trelagliptin and remogliflozin alone and in combination with Alpha Lipoic Acid on cardiac function in streptozotocin-induced diabetes mellitus in rats. ( Abdullah Ali, M; Kareem Hamad, B; Naji Alhassani, A, 2023)
"Metformin has beneficial pharmacological effects on the preservation of peripheral nerves in diabetic rats and its effects are comparable to those of ALA."1.56Metformin Preserves Peripheral Nerve Damage with Comparable Effects to Alpha Lipoic Acid in Streptozotocin/High-Fat Diet Induced Diabetic Rats. ( Jin, HY; Kim, SH; Park, TS, 2020)
"Diabetic neuropathies are a family of nerve disorders caused by diabetes."1.35Coenzyme Q(10) and alpha-lipoic acid supplementation in diabetic rats: conduction velocity distributions. ( Ayaz, M; Gokbel, H; Okudan, N; Tuncer, S, 2008)
"In alloxan-treated mice (a model of type 1 diabetes), drugs were administered orally once daily for 6 days post-alloxan treatment."1.35Hypoglycemic and beta cell protective effects of andrographolide analogue for diabetes treatment. ( Jiang, J; Larrick, JW; Wang, Y; Yu, P; Zeng, X; Zhang, Z, 2009)
" Improved endothelial function due to alpha-LA was at least partially attributed to recoupling of eNOS and increased NO bioavailability and represents a pharmacological approach to prevent major complications associated with type 2 diabetes."1.35Effects of alpha-lipoic acid on endothelial function in aged diabetic and high-fat fed rats. ( Boarder, MR; Fernandes, R; Louro, T; Nunes, E; Proença, T; Seiça, RM; Sena, CM, 2008)
"ALA plays an important role in treatment of erectile dysfunction by decreasing iNOS and increasing other isoforms of NOS."1.33The effects of alpha-lipoic acid on nitric oxide synthetase dispersion in penile function in streptozotocin-induced diabetic rats. ( Citci, S; Demirci, C; Hurdag, C; Ozkara, H; Uyaner, I, 2005)
"We hypothesized that streptozotocin diabetes in rats and mice would result in an early reduction in podocyte density and that this reduction would be prevented by antioxidants."1.33Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment. ( Brosius, FC; Saha, J; Siu, B; Smoyer, WE; Sullivan, KA, 2006)
" Our results demonstrate that the long-term administration of alpha-lipoic acid has beneficial effects on the development of diabetic retinopathy via inhibition of accumulation of oxidatively modified DNA and nitrotyrosine in the retina."1.32Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. ( Kowluru, RA; Odenbach, S, 2004)
"Substance P was depleted to 51% in the control rats (p < 0."1.31Oxidative stress participates in the breakdown of neuronal phenotype in experimental diabetic neuropathy. ( Corder, R; Hounsom, L; Patel, J; Tomlinson, DR, 2001)
"In rats treated only during pregnancy days 1 to 5 (before diabetes induction), lipoic acid failed to exert its protective effects against neural tube defects, which emphasizes the importance of the presence of lipoic acid during the organogenesis period."1.30Lipoic acid prevention of neural tube defects in offspring of rats with streptozocin-induced diabetes. ( Ayalon, N; Bashan, N; Hershkovitz, R; Khamaisi, M; Reece, EA; Trischler, H; Wiznitzer, A, 1999)
" In conclusion, this study suggests that short-term administration of LA at high dosage to normal and diabetic rats causes an inhibition of gluconeogenesis secondary to an interference with hepatic fatty acid oxidation."1.30Lipoic acid acutely induces hypoglycemia in fasting nondiabetic and diabetic rats. ( Bashan, N; Gutman, A; Khamaisi, M; Potashnik, R; Rudich, A; Tritschler, HJ, 1999)
"As thioctic acid (TA) has favourable effects on glucose metabolism, the influence of this drug at two different doses (0."1.29The influence of thioctic acid on metabolism and function of the diabetic heart. ( Bretzel, RG; Federlin, K; Lehmann, E; Lehmann, U; Strödter, D; Tritschler, HJ, 1995)
"Formation of lens opacities in vitro was correlated with lactate dehydrogenase (LDH) leakage into the incubation medium."1.29Modelling cortical cataractogenesis 17: in vitro effect of a-lipoic acid on glucose-induced lens membrane damage, a model of diabetic cataractogenesis. ( Handelman, GJ; Kilic, F; Packer, L; Serbinova, E; Trevithick, JR, 1995)

Research

Studies (149)

TimeframeStudies, this research(%)All Research%
pre-19902 (1.34)18.7374
1990's17 (11.41)18.2507
2000's57 (38.26)29.6817
2010's53 (35.57)24.3611
2020's20 (13.42)2.80

Authors

AuthorsStudies
Sajadimajd, S1
Khosravifar, M1
Bahrami, G1
Oraebosi, MI2
Olurishe, TO2
Anafi, SB2
Bisalla, M2
Ramos, CSCB1
Silva, VAPD1
Corrêa, LBNS1
Abboud, RS1
Boaventura, GT1
Chagas, MA1
Mokhtari, B1
Abdoli-Shadbad, M1
Alihemmati, A2
Javadi, A1
Badalzadeh, R2
Tanbek, K1
Ozerol, E1
Yilmaz, U1
Yilmaz, N1
Gul, M2
Colak, C1
Huang, SH1
Kuo, SL1
Chen, SJ1
Lin, JR1
Chen, YW1
Hong, ZJ1
Sytwu, HK1
Lin, GJ1
Dugbartey, GJ2
Alornyo, KK2
N'guessan, BB1
Atule, S1
Mensah, SD1
Adjei, S1
Alhakamy, NA1
Mohamed, GA1
Fahmy, UA1
Eid, BG1
Al-Rabia, MW1
Khedr, AIM1
Nasrullah, MZ1
Ibrahim, SRM1
Abdel-Naim, AB1
Ahmed, OAA1
Md, S1
Wonje, QL1
Adams, I1
Diaba, DE1
Gholami, S1
Abdullah Ali, M1
Naji Alhassani, A1
Kareem Hamad, B1
Kayhan Kuştepe, E1
Bahar, L2
Zayman, E1
Sucu, N2
Gül, S1
Eras, N1
Bagdatoglu, OT1
Yildirim, M2
Zhang, BY1
Zhang, YL1
Sun, Q2
Zhang, PA1
Wang, XX1
Xu, GY2
Hu, J2
Zhang, HH2
Kim, SH3
Park, TS4
Jin, HY4
Won, JC1
Koo, BK1
Dong, J1
Wang, Y5
Yi, S1
Zhao, T1
Xu, Y1
Davidson, EP4
Coppey, LJ5
Shevalye, H2
Obrosov, A2
Kardon, RH2
Yorek, MA6
Qin, X1
Song, ZY1
Yang, PP1
Feng, Y2
Jurisic-Erzen, D1
Starcevic-Klasan, G1
Ivanac, D1
Peharec, S1
Girotto, D1
Jerkovic, R1
Dworacka, M1
Chukanova, G1
Iskakova, S1
Kurmambayev, Y1
Wesołowska, A1
Frycz, BA1
Jagodziński, PP1
Dworacki, G1
Lee, KA2
Lee, NY1
Kim, YS1
Kim, M1
Choi, MY1
Lee, DH1
Roh, GS1
Kim, HJ1
Kang, SS1
Cho, GJ1
Hong, EK1
Choi, WS1
Tasci, I1
Demir, CF1
Kuloglu, T1
Cruz-Álvarez, LE1
Zúñiga-Romero, Á1
Huerta-Cruz, JC1
Flores-Murrieta, FJ1
Reyes-García, JG1
Araiza-Saldaña, CI1
Rocha-González, HI1
Peng, C1
Jiang, X1
Xiao, Y1
Yuan, Z1
Mao, Y1
Wang Wang, Y1
Zhang, Y1
Zhang, F1
Tang, L1
Guo, B1
Sadeghiyan Galeshkalami, N1
Abdollahi, M1
Najafi, R1
Baeeri, M1
Jamshidzade, A1
Falak, R1
Davoodzadeh Gholami, M1
Hassanzadeh, G1
Mokhtari, T1
Hassani, S1
Rahimifard, M1
Hosseini, A1
Gao, T1
Qian, S1
Shen, S1
Zhang, X1
Liu, J1
Jia, W1
Chen, Z1
Ye, J1
Feng, B1
Yan, XF1
Xue, JL1
Xu, L2
Wang, H1
Al-Rasheed, NM2
Attia, HA1
Hasan, IH1
Al-Amin, M1
Al-Ajmi, H1
Mohamad, RA1
Volchegorskii, IA3
Rassokhina, LM4
Miroshnichenko, IY2
Nebbioso, M1
Pranno, F1
Pescosolido, N1
Chen, CL1
Cheng, WS1
Chen, JL1
Chiang, CH1
Zhao, L1
Ma, X1
Deng, X1
Wu, JZ1
Baek, HS1
Dominguez, JM1
Grant, MB1
Kan, E2
Kiliçkan, E1
Ayar, A2
Çolak, R1
Berkowitz, BA3
Grady, EM1
Khetarpal, N1
Patel, A1
Roberts, R3
Li, Y1
Yan, H1
Zhang, Z2
Zhang, G1
Sun, Y1
Yu, P2
Volchegorskii, LA1
Faizullin, RM1
Pryakhina, KE1
Kalugina, AV1
Mao, ZM1
Shen, SM1
Wan, YG1
Sun, W1
Chen, HL1
Huang, MM1
Yang, JJ1
Wu, W1
Tang, HT1
Tang, RM1
Holmes, A1
Ozgun, E1
Ozgun, GS1
Gokmen, SS1
Eskıocak, S1
Sut, N1
Akıncı, M1
Goncu, E1
Cakır, E1
Alici, Ö1
Kan, EK1
Zhang, S1
Li, H2
Zhang, L1
Li, J1
Wang, R1
Wang, M1
Yorek, MS1
Al-Matubsi, HY1
Oriquat, GA1
Abu-Samak, M1
Al Hanbali, OA1
Salim, MD1
Zhang, T1
Gao, Y1
Gong, Y1
Zhou, H1
Xie, P1
Guan, S1
Yi, W1
Johnsen-Soriano, S1
Garcia-Pous, M1
Arnal, E1
Sancho-Tello, M1
Garcia-Delpech, S1
Miranda, M1
Bosch-Morell, F1
Diaz-Llopis, M1
Navea, A1
Romero, FJ1
Ayaz, M1
Tuncer, S1
Okudan, N2
Gokbel, H2
Luz, J1
Zemdegs, JC1
Amaral, LS1
Balkis Budin, S1
Othman, F1
Louis, SR1
Abu Bakar, M1
Radzi, M1
Osman, K1
Das, S1
Mohamed, J1
Sugimura, Y1
Murase, T1
Kobayashi, K1
Oyama, K1
Hayasaka, S1
Kanou, Y1
Oiso, Y1
Murata, Y1
Jiang, J1
Zeng, X1
Larrick, JW1
Yao, LS1
Wang, YT1
Chen, Y1
Dai, YT1
Bu, L1
Liu, ZM1
Kanter, M1
Sen, S1
Donmez, S1
Aktas, C1
Ustundag, S1
Erboga, M1
Lappalainen, Z2
Lappalainen, J3
Laaksonen, DE3
Oksala, KJ1
Khanna, S3
Sen, CK3
Atalay, M3
Oksala, NK2
Mohasseb, M1
Ebied, S1
Yehia, MA1
Hussein, N1
Morgado, C1
Pereira-Terra, P1
Tavares, I1
Nurullahoğlu Atalik, KE1
Canbilen, A1
Kara, I1
Li, XZ1
Yan, HD1
Wang, J1
Sudheesh, NP1
Ajith, TA1
Janardhanan, KK1
Krishnan, CV1
Miroshnichenko, IIu2
Karatug, A1
Bolkent, S1
Santos, JM1
Kowluru, RA2
Sadi, G2
Eryilmaz, N1
Tütüncüoğlu, E1
Cingir, Ş1
Güray, T2
Gao, S1
Yuan, K1
Shah, A1
Kim, JS1
Park, WH1
Mirjana, M1
Jelena, A1
Aleksandra, U1
Svetlana, D1
Nevena, G1
Jelena, M1
Goran, P1
Melita, V1
Chen, WL1
Kang, CH1
Wang, SG1
Lee, HM1
Li, CJ1
Lv, L1
Yu, DM1
Chen, SA1
Chen, HM1
Yao, YD1
Hung, CF1
Tu, CS1
Liang, YJ1
Arambašić, J2
Mihailović, M2
Uskoković, A2
Dinić, S2
Grdović, N2
Marković, J2
Poznanović, G2
Bajec, D1
Vidaković, M2
Mıcılı, SC1
Ergur, BU1
Ozoğul, C2
Sarıoğlu, S1
Bağrıyanık, HA1
Tuğyan, K1
Pekcetin, C1
Sonmez, U1
Tekmen, I1
Erbil, G1
Akdoğan, GG1
Ozyurt, D1
Buldan, Z1
Karadžić, B1
Yilmaz, O3
Ozkan, Y2
Oztürk, AI2
Erşan, Y2
Abiko, T1
Abiko, A1
Clermont, AC1
Shoelson, B1
Horio, N1
Takahashi, J1
Adamis, AP1
King, GL1
Bursell, SE1
Midaoui, AE1
Elimadi, A1
Wu, L1
Haddad, PS1
de Champlain, J1
Gellett, JS2
Maritim, AC3
Sanders, RA3
Watkins, JB3
Gibson, TM1
Cotter, MA5
Cameron, NE5
BUTTURINI, U1
Gouty, S1
Regalia, J1
Cai, F1
Helke, CJ1
Bojunga, J1
Dresar-Mayert, B1
Usadel, KH1
Kusterer, K1
Zeuzem, S1
Shotton, HR1
Broadbent, S1
Lincoln, J1
Kumar, MS1
Prashanth, KV1
Sun, L1
Zhang, JS1
Alderson, NL1
Chachich, ME1
Frizzell, N1
Canning, P1
Metz, TO1
Januszewski, AS1
Youssef, NN1
Stitt, AW1
Baynes, JW1
Thorpe, SR1
Al Ghafli, MH1
Padmanabhan, R1
Kataya, HH1
Berg, B1
Baydas, G1
Donder, E1
Kiliboz, M1
Sonkaya, E1
Tuzcu, M1
Yasar, A1
Nedzvetskii, VS1
Odenbach, S1
Berryman, AM1
Dene, BA1
Bhatti, F1
Mankhey, RW1
Asico, L1
Quinn, MT1
Welch, WJ1
Maric, C1
Lateef, H1
Aslam, MN1
Stevens, MJ5
Varani, J1
Hurdag, C1
Ozkara, H1
Citci, S1
Uyaner, I1
Demirci, C1
Lin, J1
Bierhaus, A1
Bugert, P1
Dietrich, N1
Vom Hagen, F1
Nawroth, P1
Brownlee, M1
Hammes, HP1
Siu, B1
Saha, J1
Smoyer, WE1
Sullivan, KA1
Brosius, FC1
Yi, X1
Maeda, N1
Luan, H2
Price, SA1
Gardiner, NJ1
Duran-Jimenez, B1
Zeef, LA1
Obrosova, IG4
Tomlinson, DR5
Pitel, S1
Raccah, D1
Gerbi, A1
Pieroni, G1
Vague, P1
Coste, TC1
Kaarniranta, K1
Stemmler, A1
Gradianu, M1
Sena, CM1
Nunes, E1
Louro, T1
Proença, T1
Fernandes, R1
Boarder, MR1
Seiça, RM1
Winiarska, K1
Malinska, D1
Szymanski, K1
Dudziak, M1
Bryla, J1
Jiang, YJ1
Gong, DX1
Liu, HB1
Yang, CM1
Sun, ZX1
Kong, CZ1
Nagamatsu, M1
Nickander, KK2
Schmelzer, JD2
Raya, A1
Wittrock, DA1
Tritschler, H4
Low, PA2
Packer, L2
Faust, A1
Burkart, V1
Ulrich, H1
Weischer, CH1
Kolb, H1
Strödter, D1
Lehmann, E1
Lehmann, U1
Tritschler, HJ4
Bretzel, RG1
Federlin, K1
Kilic, F1
Handelman, GJ1
Serbinova, E1
Trevithick, JR1
Garrett, NE1
Malcangio, M1
Dewhurst, M1
Khamaisi, M4
Potashnik, R2
Tirosh, A1
Demshchak, E1
Rudich, A3
Wessel, K1
Bashan, N4
Horrobin, DH1
Hounsom, L2
Horrobin, DF1
Corder, R2
Black, K1
Qu, X1
Seale, JP1
Donnelly, R1
Obrosova, I2
Cao, X2
Greene, DA3
Wiznitzer, A1
Ayalon, N1
Hershkovitz, R1
Reece, EA1
Trischler, H1
Keegan, A1
Gutman, A1
Patel, J2
Kishi, Y1
Yao, JK1
Zollman, PJ1
Cakatay, U2
Telci, A2
Kayali, R2
Sivas, A1
Akçay, T2
Fathallah, L2
Van Huysen, C1
Melhem, MF2
Craven, PA2
Derubertis, FR2
Biessels, GJ2
Smale, S1
Duis, SE1
Kamal, A1
Gispen, WH1
Koçak, G2
Aktan, F1
Canbolat, O1
Elbeğ, S1
Yildizoglu-Ari, N1
Karasu, C2
Beeri, I1
Pessler, D1
Friger, M1
Gavrilov, V1
Lang, HJ1
van Dam, PS1
van Asbeck, BS1
Van Oirschot, JF1
Hamers, FP1
Marx, JJ1
Jack, AM1
Dunlap, JA1
Lund, DD1
Ford, I1
Greaves, M1
Minchenko, AG1
Marinescu, V1
Kennedy, A1
Stockert, CM1
Frank, RN1
Liachenko, J1
Piotrowski, P1
Wierzbicka, K1
Smiałek, M1
Dinçer, Y1
Yilmaz, IA1
Singh, HP1
Bowman, RH1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2) Randomised, Double-blind,Placebo-controlled Multicentre Trial With 4 Parallel Groups[NCT00328601]Phase 3170 participants Interventional2005-02-28Completed
Phase 1 Study To Determine the Effects of Short Term Near-infrared Light (NIR) Therapy on Anatomic and Functional Abnormalities of Diabetic Macular Edema, and Assess Safety of Short Term Near-infrared Light Therapy in Eyes With Diabetic Macular Edema.[NCT00846092]Phase 14 participants (Actual)Interventional2007-11-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for thioctic acid and Alloxan Diabetes

ArticleYear
Lipoic acid in animal models and clinical use in diabetic retinopathy.
    Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:13

    Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Humans; Thioctic Acid

2013
Antioxidant properties of lipoic acid and its therapeutic effects in prevention of diabetes complications and cataracts.
    Annals of the New York Academy of Sciences, 1994, Nov-17, Volume: 738

    Topics: Animals; Antimetabolites; Antioxidants; Buthionine Sulfoximine; Cataract; Diabetes Mellitus, Experim

1994

Other Studies

147 other studies available for thioctic acid and Alloxan Diabetes

ArticleYear
Anti-Diabetic Effects of Isolated Lipids from Natural Sources through Modulation of Angiogenesis.
    Current molecular pharmacology, 2022, Volume: 15, Issue:4

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Fatty Acids, Omega-3; Humans; Linsee

2022
Diurnal efficacy of alpha-lipoic acid/nifedipine/glimepiride combination mitigates diabetic neuropathies in rats.
    Annales pharmaceutiques francaises, 2022, Volume: 80, Issue:3

    Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Nifedipine; Rats; Sul

2022
Long-Term Alpha-Lipoic Acid (ALA) Antioxidant Therapy Reduces Damage in the Cardiovascular System of Streptozotocin-Induced Diabetic Rats.
    Journal of dietary supplements, 2023, Volume: 20, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Aorta; Diabetes Mellitus, Experimental; Male; Rats;

2023
Alpha-lipoic acid preconditioning plus ischemic postconditioning provides additional protection against myocardial reperfusion injury of diabetic rats: modulation of autophagy and mitochondrial function.
    Molecular biology reports, 2022, Volume: 49, Issue:3

    Topics: Animals; Autophagy; Diabetes Mellitus, Experimental; Ischemic Postconditioning; Ischemic Preconditio

2022
Alpha lipoic acid decreases neuronal damage on brain tissue of STZ-induced diabetic rats.
    Physiology & behavior, 2022, 05-01, Volume: 248

    Topics: Animals; Antioxidants; Brain; Diabetes Mellitus, Experimental; Male; Oxidative Stress; Rats; Rats, W

2022
Alpha-Lipoic Acid Inhibits Spontaneous Diabetes and Autoimmune Recurrence in Non-Obese Diabetic Mice by Enhancing Differentiation of Regulatory T Cells and Showed Potential for Use in Cell Therapies for the Treatment of Type 1 Diabetes.
    International journal of molecular sciences, 2022, Jan-21, Volume: 23, Issue:3

    Topics: Animals; Antioxidants; Autoimmunity; Cell Differentiation; Diabetes Mellitus, Experimental; Diabetes

2022
Supplementation of conventional anti-diabetic therapy with alpha-lipoic acid prevents early development and progression of diabetic nephropathy.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 149

    Topics: Animals; Antioxidants; Creatinine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabe

2022
Thioctamer: a novel thioctic acid-glatiramer acetate nanoconjugate expedites wound healing in diabetic rats.
    Drug delivery, 2022, Volume: 29, Issue:1

    Topics: Animals; Diabetes Mellitus, Experimental; Glatiramer Acetate; Hydrogels; Interleukin-6; Nanoconjugat

2022
Alpha-lipoic acid treatment improves adverse cardiac remodelling in the diabetic heart - The role of cardiac hydrogen sulfide-synthesizing enzymes.
    Biochemical pharmacology, 2022, Volume: 203

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Hydr

2022
Alpha-lipoic acid enhances ischemic postconditioning-mediated improvement of myocardial infarction and apoptosis in diabetic rats with ischemia/reperfusion injury.
    Canadian journal of physiology and pharmacology, 2023, Dec-01, Volume: 101, Issue:12

    Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Diabetes Mellitus, Experimental; Ischemic Postcondit

2023
Impacts of trelagliptin and remogliflozin alone and in combination with Alpha Lipoic Acid on cardiac function in streptozotocin-induced diabetes mellitus in rats.
    Cellular and molecular biology (Noisy-le-Grand, France), 2023, Sep-30, Volume: 69, Issue:9

    Topics: Animals; Biomarkers; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Inflammation; Male;

2023
A light microscopic investigation of the renoprotective effects of α-lipoic acid and α-tocopherol in an experimental diabetic rat model.
    Biotechnic & histochemistry : official publication of the Biological Stain Commission, 2020, Volume: 95, Issue:4

    Topics: alpha-Tocopherol; Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Ma

2020
Adrenomedullin expression in aortic artery wall of diabetic rats given alpha lipoic acid.
    Pharmacological reports : PR, 2020, Volume: 72, Issue:4

    Topics: Adrenomedullin; Animals; Antioxidants; Aorta; Diabetes Mellitus, Experimental; Endothelium, Vascular

2020
Alpha-lipoic acid downregulates TRPV1 receptor via NF-κB and attenuates neuropathic pain in rats with diabetes.
    CNS neuroscience & therapeutics, 2020, Volume: 26, Issue:7

    Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Female; Ganglia, Spinal; Neuralgia; NF-kappa

2020
Metformin Preserves Peripheral Nerve Damage with Comparable Effects to Alpha Lipoic Acid in Streptozotocin/High-Fat Diet Induced Diabetic Rats.
    Diabetes & metabolism journal, 2020, Volume: 44, Issue:6

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Diet, High-Fat; Male; Metformin; Ra

2020
Chronopharmacology of the alpha-lipoic acid/nifedipine/glimepiride combination in the amelioration of retinopathy in rats.
    Chronobiology international, 2021, Volume: 38, Issue:3

    Topics: Animals; Antioxidants; Circadian Rhythm; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Nife

2021
The Anti-Diabetic Drug Metformin from the Neuropathy Perspective.
    Diabetes & metabolism journal, 2020, Volume: 44, Issue:6

    Topics: Animals; Diabetes Mellitus, Experimental; Diet, High-Fat; Metformin; Peripheral Nerves; Pharmaceutic

2020
Metformin Preserves Peripheral Nerve Damage with Comparable Effects to Alpha Lipoic Acid in Streptozotocin/High-Fat Diet Induced Diabetic Rats (Diabetes Metab J 2020;44:842-53).
    Diabetes & metabolism journal, 2021, Volume: 45, Issue:1

    Topics: Animals; Diabetes Mellitus, Experimental; Diet, High-Fat; Metformin; Peripheral Nerves; Rats; Strept

2021
Metformin Preserves Peripheral Nerve Damage with Comparable Effects to Alpha Lipoic Acid in Streptozotocin/High-Fat Diet Induced Diabetic Rats (Diabetes Metab J 2020;44:842-53).
    Diabetes & metabolism journal, 2021, Volume: 45, Issue:1

    Topics: Animals; Diabetes Mellitus, Experimental; Diet, High-Fat; Metformin; Peripheral Nerves; Rats; Strept

2021
α-Lipoic acid ameliorates renal fibrosis in diabetic rats through TGF-β1/Smads signaling pathway.
    Minerva medica, 2022, Volume: 113, Issue:1

    Topics: Animals; Diabetes Mellitus, Experimental; Fibrosis; Humans; Kidney Diseases; Rats; Signal Transducti

2022
Impaired Corneal Sensation and Nerve Loss in a Type 2 Rat Model of Chronic Diabetes Is Reversible With Combination Therapy of Menhaden Oil, α-Lipoic Acid, and Enalapril.
    Cornea, 2017, Volume: 36, Issue:6

    Topics: Adiponectin; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Cornea; Diabetes Mell

2017
Alpha-lipoic Acid suppresses P2X receptor activities and visceral hypersensitivity to colorectal distention in diabetic rats.
    Scientific reports, 2017, 06-28, Volume: 7, Issue:1

    Topics: Animals; Colon; Diabetes Complications; Diabetes Mellitus, Experimental; Disease Models, Animal; Fem

2017
The effects of alpha-lipoic acid on diabetic myopathy.
    Journal of endocrinological investigation, 2018, Volume: 41, Issue:2

    Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Male; Muscle Fibe

2018
New arguments for beneficial effects of alpha-lipoic acid on the cardiovascular system in the course of type 2 diabetes.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2018, May-30, Volume: 117

    Topics: Animals; Antioxidants; Aorta; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Typ

2018
Comparison of peripheral nerve protection between insulin-based glucose control and alpha lipoic acid (ALA) in the streptozotocin (STZ)-induced diabetic rat.
    Endocrine, 2018, Volume: 61, Issue:1

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Hypoglycemic Agents;

2018
Alpha-lipoic acid reduces retinal cell death in diabetic mice.
    Biochemical and biophysical research communications, 2018, 09-10, Volume: 503, Issue:3

    Topics: Administration, Oral; AMP-Activated Protein Kinases; Animals; Cell Death; Cells, Cultured; Diabetes

2018
Effects of Alpha Lipoic Acid on Loss of Myelin Sheath of Sciatic Nerve in Experimentally Induced Diabetic Rats.
    Medical archives (Sarajevo, Bosnia and Herzegovina), 2018, Volume: 72, Issue:3

    Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Anima

2018
Antiallodynic interaction and motor performance of the pregabalin/thioctic acid and pregabalin/α-tocopherol combinations in neonatal streptozotocin-induced diabetic rats.
    Drug development research, 2018, Volume: 79, Issue:7

    Topics: alpha-Tocopherol; Analgesics; Animals; Animals, Newborn; Antioxidants; Diabetes Mellitus, Experiment

2018
[Alpha-lipoamide inhibits renal inflammation and collagen 4 production in diabetic rats and its mechanism].
    Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2018, Volume: 34, Issue:7

    Topics: Animals; Collagen Type IV; Diabetes Mellitus, Experimental; Inflammation; Interleukin-6; Kidney; NLR

2018
Alpha-lipoic acid and coenzyme Q10 combination ameliorates experimental diabetic neuropathy by modulating oxidative stress and apoptosis.
    Life sciences, 2019, Jan-01, Volume: 216

    Topics: Administration, Oral; Animals; Apoptosis; Biomarkers; Blotting, Western; Caspase 3; Diabetes Mellitu

2019
Reduction of mitochondrial 3-oxoacyl-ACP synthase (OXSM) by hyperglycemia is associated with deficiency of α-lipoic acid synthetic pathway in kidney of diabetic mice.
    Biochemical and biophysical research communications, 2019, 04-23, Volume: 512, Issue:1

    Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase; 3T3-L1 Cells; Animals; Biosynthetic Pathways; Diabetes Me

2019
The protective effects of α-lipoic acid on kidneys in type 2 diabetic Goto-Kakisaki rats via reducing oxidative stress.
    International journal of molecular sciences, 2013, Mar-26, Volume: 14, Issue:4

    Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glu

2013
Adverse cardiac responses to alpha-lipoic acid in a rat-diabetic model: possible mechanisms?
    Journal of physiology and biochemistry, 2013, Volume: 69, Issue:4

    Topics: Animals; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Experimental; Glycation End Products

2013
Cerebroprotective effects of emoxipin, reamberin, and mexidol in alloxan diabetes.
    Bulletin of experimental biology and medicine, 2013, Volume: 155, Issue:1

    Topics: Alloxan; Animals; Astrocytes; Cerebral Cortex; Diabetes Mellitus, Experimental; Diencephalon; Female

2013
Potential of nonoral α-lipoic acid aqueous formulations to reduce ocular microvascular complications in a streptozotocin-induced diabetic rat model.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2013, Volume: 29, Issue:8

    Topics: Administration, Ophthalmic; Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Retinop

2013
Oxidative stress impairs IKCa- and SKCa-mediated vasodilatation in mesenteric arteries from diabetic rats.
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2013, Volume: 33, Issue:7

    Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Human Umbilical Vein Endothelial Cells; H

2013
The neuroprotective benefit from pioglitazone (PIO) addition on the alpha lipoic acid (ALA)-based treatment in experimental diabetic rats.
    Endocrine, 2014, Volume: 47, Issue:3

    Topics: Animals; Axons; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Drug Therapy,

2014
Combination therapies prevent the neuropathic, proinflammatory characteristics of bone marrow in streptozotocin-induced diabetic rats.
    Diabetes, 2015, Volume: 64, Issue:2

    Topics: Adipose Tissue; Animals; Bone Marrow; Cytokines; Diabetes Mellitus, Experimental; Diabetic Neuropath

2015
Effects of two antioxidants; α-lipoic acid and fisetin against diabetic cataract in mice.
    International ophthalmology, 2015, Volume: 35, Issue:1

    Topics: Animals; Antioxidants; Cataract; Diabetes Complications; Diabetes Mellitus, Experimental; Disease Pr

2015
Oxidative stress and light-evoked responses of the posterior segment in a mouse model of diabetic retinopathy.
    Investigative ophthalmology & visual science, 2015, Jan-08, Volume: 56, Issue:1

    Topics: Animals; Antioxidants; Choroid; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Female; Light

2015
Andrographolide derivative AL-1 improves insulin resistance through down-regulation of NF-κB signalling pathway.
    British journal of pharmacology, 2015, Volume: 172, Issue:12

    Topics: Andrographis; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diterpenes; Dose-

2015
[Anxiolytic and antidepressant effects of 3-oxypiridine and succinic acid derivatives in alloxan diabetes].
    Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 2015, Volume: 101, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Depression; Diabetes Mellitus, Experimental; Humans; Hypergly

2015
Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
    Journal of ethnopharmacology, 2015, Sep-15, Volume: 173

    Topics: Abelmoschus; Animals; Antioxidants; Capsules; Diabetes Mellitus, Experimental; Diabetic Nephropathie

2015
Effect of combination therapy consisting of enalapril, α-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat.
    European journal of pharmacology, 2015, Oct-15, Volume: 765

    Topics: Animals; Cornea; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Neuropathies;

2015
Effect of Lipoic Acid on Serum Paraoxonase-1 and Paraoxonase-3 Protein Levels and Activities in Diabetic Rats.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2019, Volume: 127, Issue:6

    Topics: Animals; Aryldialkylphosphatase; Diabetes Mellitus, Experimental; Male; Random Allocation; Rats; Rat

2019
Effects of alpha-lipoic acid on retinal ganglion cells, retinal thicknesses, and VEGF production in an experimental model of diabetes.
    International ophthalmology, 2017, Volume: 37, Issue:6

    Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Male; Mice, Inbred BAL

2017
Effects of troxerutin on cognitive deficits and glutamate cysteine ligase subunits in the hippocampus of streptozotocin-induced type 1 diabetes mellitus rats.
    Brain research, 2017, 02-15, Volume: 1657

    Topics: Animals; Cognition Disorders; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Evalu

2017
Early vs. late intervention of high fat/low dose streptozotocin treated C57Bl/6J mice with enalapril, α-lipoic acid, menhaden oil or their combination: Effect on diabetic neuropathy related endpoints.
    Neuropharmacology, 2017, Volume: 116

    Topics: Acute Disease; Animals; Chronic Disease; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dru

2017
Effects of Lipoic Acid Supplementation on Activities of Cyclooxygenases and Levels of Prostaglandins E
    Journal of diabetes research, 2016, Volume: 2016

    Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dinoprost; Dinoprostone; Disea

2016
Tang-Luo-Ning Improves Mitochondrial Antioxidase Activity in Dorsal Root Ganglia of Diabetic Rats: A Proteomics Study.
    BioMed research international, 2017, Volume: 2017

    Topics: Animals; Blood Glucose; Chromatography, Ion Exchange; Diabetes Mellitus, Experimental; Disease Model

2017
Early lipoic acid intake protects retina of diabetic mice.
    Free radical research, 2008, Volume: 42, Issue:7

    Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Drug Administration Sc

2008
Coenzyme Q(10) and alpha-lipoic acid supplementation in diabetic rats: conduction velocity distributions.
    Methods and findings in experimental and clinical pharmacology, 2008, Volume: 30, Issue:5

    Topics: Action Potentials; Animals; Antioxidants; Blood Glucose; Body Weight; Diabetes Mellitus, Experimenta

2008
Chronic lipoic acid treatment worsens energy imbalances in streptozotocin-induced diabetic rats.
    Diabetes & metabolism, 2009, Volume: 35, Issue:2

    Topics: Animals; Blood Glucose; Body Composition; Body Weight; Diabetes Mellitus, Experimental; Eating; Ener

2009
Effect of alpha lipoic acid on oxidative stress and vascular wall of diabetic rats.
    Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie, 2009, Volume: 50, Issue:1

    Topics: Animals; Aorta, Thoracic; Ascorbic Acid; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental

2009
Alpha-lipoic acid reduces congenital malformations in the offspring of diabetic mice.
    Diabetes/metabolism research and reviews, 2009, Volume: 25, Issue:3

    Topics: Animals; Blood Glucose; Cardiovascular Abnormalities; Congenital Abnormalities; Diabetes Mellitus, E

2009
Hypoglycemic and beta cell protective effects of andrographolide analogue for diabetes treatment.
    Journal of translational medicine, 2009, Jul-16, Volume: 7

    Topics: Alloxan; Animals; Blood Glucose; Cytoprotection; Diabetes Mellitus, Experimental; Diabetes Mellitus,

2009
[Expressions of NOS isoforms in the cavernous tissues of diabetic rat models].
    Zhonghua nan ke xue = National journal of andrology, 2009, Volume: 15, Issue:10

    Topics: Animals; Diabetes Mellitus, Experimental; Erectile Dysfunction; Insulin; Male; Nitric Oxide Synthase

2009
[Effects of alpha lipoic acid on hypothalamus-pituitary-adrenal axis in rats].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2010, Volume: 30, Issue:4

    Topics: Animals; Diabetes Mellitus, Experimental; Hypothalamo-Hypophyseal System; Male; Pituitary-Adrenal Sy

2010
Protective effects of irbesartan and alpha lipoic acid in STZ-induced diabetic nephropathy in rats.
    Renal failure, 2010, Volume: 32, Issue:4

    Topics: Animals; Biphenyl Compounds; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Immuno

2010
Acute exercise and thioredoxin-1 in rat brain, and alpha-lipoic acid and thioredoxin-interacting protein response, in diabetes.
    International journal of sport nutrition and exercise metabolism, 2010, Volume: 20, Issue:3

    Topics: Animals; Antioxidants; Blood Glucose; Brain; Diabetes Mellitus, Experimental; Glutathione; Glutathio

2010
Alpha-lipoic acid does not alter stress protein response to acute exercise in diabetic brain.
    Cell biochemistry and function, 2010, Dec-02, Volume: 28, Issue:8

    Topics: Animals; Antioxidants; Brain; Diabetes Mellitus, Experimental; HSP70 Heat-Shock Proteins; HSP90 Heat

2010
Testicular oxidative damage and role of combined antioxidant supplementation in experimental diabetic rats.
    Journal of physiology and biochemistry, 2011, Volume: 67, Issue:2

    Topics: Animals; Antioxidants; Apoptosis; Ascorbic Acid; Caspase 3; Diabetes Mellitus, Experimental; Dietary

2011
α-Lipoic acid normalizes nociceptive neuronal activity at the spinal cord of diabetic rats.
    Diabetes, obesity & metabolism, 2011, Volume: 13, Issue:8

    Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Male; Nociceptors; Oxidative Stress; Rats; R

2011
Alpha lipoic acid treatment improved endothelium-dependent relaxation in diabetic rat aorta.
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2011, Volume: 131, Issue:5

    Topics: Animals; Antioxidants; Aorta; Diabetes Mellitus, Experimental; Endothelium, Vascular; In Vitro Techn

2011
[Extract of Ginkgo biloba and alpha-lipoic acid attenuate advanced glycation end products accumulation and RAGE expression in diabetic nephropathy rats].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2011, Volume: 31, Issue:4

    Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Ginkgo biloba; Glyca

2011
Palladium-α-lipoic acid complex attenuates alloxan-induced hyperglycemia and enhances the declined blood antioxidant status in diabetic rats.
    Journal of diabetes, 2011, Volume: 3, Issue:4

    Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Glutathion

2011
[Cerebroprotective effect of 3-oxypyridine and succinic acid derivatives in acute phase of alloxan-induced diabetes mellitus in rats].
    Eksperimental'naia i klinicheskaia farmakologiia, 2011, Volume: 74, Issue:5

    Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Anim

2011
The potential role of combined antioxidant treatment on pancreas of STZ-diabetic mice.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2013, Volume: 65, Issue:3

    Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, D

2013
Role of mitochondria biogenesis in the metabolic memory associated with the continued progression of diabetic retinopathy and its regulation by lipoic acid.
    Investigative ophthalmology & visual science, 2011, Nov-11, Volume: 52, Issue:12

    Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Progression; D

2011
Changes in expression profiles of antioxidant enzymes in diabetic rat kidneys.
    Diabetes/metabolism research and reviews, 2012, Volume: 28, Issue:3

    Topics: Animals; Antioxidants; Ascorbic Acid; Catalase; Diabetes Mellitus, Experimental; Drug Combinations;

2012
Suppression of high pacing-induced ANP secretion by antioxidants in isolated rat atria.
    Peptides, 2011, Volume: 32, Issue:12

    Topics: Acetophenones; Acetylcysteine; Animals; Antioxidants; Atrial Function; Atrial Natriuretic Factor; Bl

2011
Alpha-lipoic acid preserves the structural and functional integrity of red blood cells by adjusting the redox disturbance and decreasing O-GlcNAc modifications of antioxidant enzymes and heat shock proteins in diabetic rats.
    European journal of nutrition, 2012, Volume: 51, Issue:8

    Topics: Acetylglucosamine; Animals; Antioxidants; Catalase; Diabetes Mellitus, Experimental; Electrophoresis

2012
[Antihypoxic effect of 3-hydroxypyridine and succinic acid derivatives and their nootropic action in alloxan diabetes].
    Eksperimental'naia i klinicheskaia farmakologiia, 2011, Volume: 74, Issue:12

    Topics: Alloxan; Animals; Conditioning, Classical; Diabetes Mellitus, Experimental; Diabetic Neuropathies; D

2011
α-Lipoic acid regulates lipid metabolism through induction of sirtuin 1 (SIRT1) and activation of AMP-activated protein kinase.
    Diabetologia, 2012, Volume: 55, Issue:6

    Topics: AMP-Activated Protein Kinases; Animals; Cell Line; Diabetes Mellitus, Experimental; Lipid Metabolism

2012
Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.
    Cardiovascular diabetology, 2012, Jun-19, Volume: 11

    Topics: Actins; Animals; Blotting, Western; Cardiac Catheterization; Cardiotonic Agents; Cell Differentiatio

2012
Topical treatment with anti-oxidants and Au nanoparticles promote healing of diabetic wound through receptor for advance glycation end-products.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2012, Dec-18, Volume: 47, Issue:5

    Topics: Administration, Topical; Animals; Antioxidants; Catechin; Cell Line; Diabetes Mellitus, Experimental

2012
Alpha-lipoic acid upregulates antioxidant enzyme gene expression and enzymatic activity in diabetic rat kidneys through an O-GlcNAc-dependent mechanism.
    European journal of nutrition, 2013, Volume: 52, Issue:5

    Topics: Acetylglucosamine; Animals; Antioxidants; Blood Glucose; Catalase; Diabetes Mellitus, Experimental;

2013
Effects of lipoic acid in an experimentally induced hypertensive and diabetic rat model.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2013, Volume: 35, Issue:5

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Hypertensi

2013
Decreased O-GlcNAcylation of the key proteins in kinase and redox signalling pathways is a novel mechanism of the beneficial effect of α-lipoic acid in diabetic liver.
    The British journal of nutrition, 2013, Aug-28, Volume: 110, Issue:3

    Topics: Aminoacylation; Animals; Antioxidants; Catalase; CCAAT-Binding Factor; Diabetes Mellitus, Experiment

2013
Effects of alpha lipoic acid, ascorbic acid-6-palmitate, and fish oil on the glutathione, malonaldehyde, and fatty acids levels in erythrocytes of streptozotocin induced diabetic male rats.
    Journal of cellular biochemistry, 2002, Volume: 86, Issue:3

    Topics: Animals; Antioxidants; Ascorbic Acid; Cholesterol; Diabetes Mellitus, Experimental; Erythrocyte Memb

2002
Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes: role of oxidants and protein kinase-C activation.
    Diabetes, 2003, Volume: 52, Issue:3

    Topics: alpha-Tocopherol; Animals; Antioxidants; Blood Flow Velocity; Diabetes Mellitus, Experimental; Diabe

2003
Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production.
    American journal of hypertension, 2003, Volume: 16, Issue:3

    Topics: Animals; Antioxidants; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Glucose; Glycat

2003
Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation.
    Free radical research, 2003, Volume: 37, Issue:1

    Topics: Animals; Arginine; Arterioles; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetic Neuropathi

2003
Effects of alpha-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats.
    The Journal of nutritional biochemistry, 2003, Volume: 14, Issue:5

    Topics: Animals; Antioxidants; Biomarkers; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Diabete

2003
Effects of alpha-lipoic acid on impaired gastric fundus innervation in diabetic rats.
    Free radical biology & medicine, 2003, Jul-15, Volume: 35, Issue:2

    Topics: Animals; Diabetes Mellitus, Experimental; Gastric Fundus; In Vitro Techniques; Injections, Intraperi

2003
[Clinical and experimental aspects of thioctic acid].
    Giornale di clinica medica, 1955, Volume: 36, Issue:12

    Topics: Acids; Animals; Diabetes Mellitus, Experimental; Glycosides; Lipid Metabolism; Liver Diseases; Thioc

1955
Alpha-lipoic acid treatment prevents the diabetes-induced attenuation of the afferent limb of the baroreceptor reflex in rats.
    Autonomic neuroscience : basic & clinical, 2003, Oct-31, Volume: 108, Issue:1-2

    Topics: Afferent Pathways; Animals; Baroreflex; Diabetes Mellitus, Experimental; Genes, fos; Male; Malondial

2003
Antioxidative treatment reverses imbalances of nitric oxide synthase isoform expression and attenuates tissue-cGMP activation in diabetic rats.
    Biochemical and biophysical research communications, 2004, Apr-09, Volume: 316, Issue:3

    Topics: Animals; Antioxidants; Apoptosis; Blood Glucose; Cyclic GMP; Diabetes Mellitus, Experimental; DNA Pr

2004
Prevention and partial reversal of diabetes-induced changes in enteric nerves of the rat ileum by combined treatment with alpha-lipoic acid and evening primrose oil.
    Autonomic neuroscience : basic & clinical, 2004, Mar-31, Volume: 111, Issue:1

    Topics: Animals; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dr

2004
alpha-Lipoic acid ameliorates altered colonic contractility and intestinal transit in STZ-diabetic rats.
    Indian journal of experimental biology, 2004, Volume: 42, Issue:3

    Topics: Acetylcholine; Animals; Antioxidants; Body Weight; Colon; Diabetes Mellitus, Experimental; Female; I

2004
[Effects of DL-alpha-lipoic acid on the experimentally induced diabetic cataract in rats].
    [Zhonghua yan ke za zhi] Chinese journal of ophthalmology, 2004, Volume: 40, Issue:3

    Topics: Animals; Antioxidants; Blood Glucose; Cataract; Diabetes Mellitus, Experimental; Disease Models, Ani

2004
Effect of antioxidants and ACE inhibition on chemical modification of proteins and progression of nephropathy in the streptozotocin diabetic rat.
    Diabetologia, 2004, Volume: 47, Issue:8

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, E

2004
Effects of alpha-lipoic acid supplementation on maternal diabetes-induced growth retardation and congenital anomalies in rat fetuses.
    Molecular and cellular biochemistry, 2004, Volume: 261, Issue:1-2

    Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Bone Development; Diabetes Mellitus, Experimental

2004
Neuroprotection by alpha-lipoic acid in streptozotocin-induced diabetes.
    Biochemistry. Biokhimiia, 2004, Volume: 69, Issue:9

    Topics: Animals; Antioxidants; Biomarkers; Brain Chemistry; Diabetes Mellitus, Experimental; Diabetic Neurop

2004
Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats.
    Diabetes, 2004, Volume: 53, Issue:12

    Topics: Animals; Cell Death; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Male; Oxidative Stress;

2004
Influence of treatment of diabetic rats with combinations of pycnogenol, beta-carotene, and alpha-lipoic acid on parameters of oxidative stress.
    Journal of biochemical and molecular toxicology, 2004, Volume: 18, Issue:6

    Topics: Animals; Antioxidants; beta Carotene; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Fe

2004
Effects of antioxidant treatment on normal and diabetic rat retinal enzyme activities.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2005, Volume: 21, Issue:1

    Topics: Animals; Antioxidants; beta Carotene; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Drug Co

2005
Mechanisms of antioxidant and pro-oxidant effects of alpha-lipoic acid in the diabetic and nondiabetic kidney.
    Kidney international, 2005, Volume: 67, Issue:4

    Topics: Albuminuria; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephrop

2005
Pretreatment of diabetic rats with lipoic acid improves healing of subsequently-induced abrasion wounds.
    Archives of dermatological research, 2005, Volume: 297, Issue:2

    Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Endothelial Cells; Fibroblasts

2005
Effects of triple antioxidant combination (vitamin E, vitamin C and alpha-lipoic acid) with insulin on lipid and cholesterol levels and fatty acid composition of brain tissue in experimental diabetic and non-diabetic rats.
    Cell biology international, 2005, Volume: 29, Issue:9

    Topics: Animals; Antioxidants; Ascorbic Acid; Brain; Cholesterol; Diabetes Mellitus, Experimental; Fatty Aci

2005
The effects of alpha-lipoic acid on nitric oxide synthetase dispersion in penile function in streptozotocin-induced diabetic rats.
    International journal of tissue reactions, 2005, Volume: 27, Issue:3

    Topics: Animals; Antioxidants; Diabetes Complications; Diabetes Mellitus, Experimental; Erectile Dysfunction

2005
Effect of R-(+)-alpha-lipoic acid on experimental diabetic retinopathy.
    Diabetologia, 2006, Volume: 49, Issue:5

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Male; NF-kappa B; Rats; Rats, Wistar

2006
Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment.
    BMC nephrology, 2006, Mar-15, Volume: 7

    Topics: Animals; Antioxidants; Cell Count; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Male; Mi

2006
alpha-Lipoic acid prevents the increase in atherosclerosis induced by diabetes in apolipoprotein E-deficient mice fed high-fat/low-cholesterol diet.
    Diabetes, 2006, Volume: 55, Issue:8

    Topics: Animals; Antioxidants; Apolipoproteins E; Aryldialkylphosphatase; Atherosclerosis; Biomarkers; Blood

2006
alpha-lipoic acid corrects late-phase supernormal retinal oxygenation response in experimental diabetic retinopathy.
    Investigative ophthalmology & visual science, 2006, Volume: 47, Issue:9

    Topics: Animals; Antioxidants; Carbon Dioxide; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Hypero

2006
Thioredoxin interacting protein is increased in sensory neurons in experimental diabetes.
    Brain research, 2006, Oct-20, Volume: 1116, Issue:1

    Topics: Animals; Antioxidants; Blotting, Western; Carrier Proteins; Cell Cycle Proteins; Cells, Cultured; Di

2006
At low doses, a gamma-linolenic acid-lipoic acid conjugate is more effective than docosahexaenoic acid-enriched phospholipids in preventing neuropathy in diabetic rats.
    The Journal of nutrition, 2007, Volume: 137, Issue:2

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Docosahexaenoic Acids; Dose-Respons

2007
Alpha-lipoic Acid modulates heat shock factor-1 expression in streptozotocin-induced diabetic rat kidney.
    Antioxidants & redox signaling, 2007, Volume: 9, Issue:4

    Topics: Analysis of Variance; Animals; Blotting, Western; Diabetes Mellitus, Experimental; Diabetic Nephropa

2007
Impaired apparent ion demand in experimental diabetic retinopathy: correction by lipoic Acid.
    Investigative ophthalmology & visual science, 2007, Volume: 48, Issue:10

    Topics: Animals; Antioxidants; Blood-Retinal Barrier; Capillary Permeability; Diabetes Mellitus, Experimenta

2007
Effects of alpha-lipoic acid on endothelial function in aged diabetic and high-fat fed rats.
    British journal of pharmacology, 2008, Volume: 153, Issue:5

    Topics: Aging; Animals; Antioxidants; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type

2008
Effect of vitamin C and lipoic acid on streptozotocin-induced diabetes gene expression: mRNA and protein expressions of Cu-Zn SOD and catalase.
    Molecular and cellular biochemistry, 2008, Volume: 309, Issue:1-2

    Topics: Actins; Animals; Antioxidants; Ascorbic Acid; Blotting, Western; Catalase; Densitometry; Diabetes Me

2008
Lipoic acid ameliorates oxidative stress and renal injury in alloxan diabetic rabbits.
    Biochimie, 2008, Volume: 90, Issue:3

    Topics: Animals; Antioxidants; Blood Glucose; Creatine; Diabetes Mellitus, Experimental; Diabetic Nephropath

2008
Ability of alpha-lipoic acid to reverse the diabetic cystopathy in a rat model.
    Acta pharmacologica Sinica, 2008, Volume: 29, Issue:6

    Topics: Animals; Antioxidants; Catalase; Diabetes Complications; Diabetes Mellitus, Experimental; Male; Malo

2008
Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy.
    Diabetes care, 1995, Volume: 18, Issue:8

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Ganglia, Spinal; Glutathione; Human

1995
Effect of lipoic acid on cyclophosphamide-induced diabetes and insulitis in non-obese diabetic mice.
    International journal of immunopharmacology, 1994, Volume: 16, Issue:1

    Topics: Animals; Antioxidants; Cyclophosphamide; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1;

1994
The influence of thioctic acid on metabolism and function of the diabetic heart.
    Diabetes research and clinical practice, 1995, Volume: 29, Issue:1

    Topics: Adenosine Triphosphate; Animals; Cardiac Output; Cardiomyopathies; Diabetes Mellitus, Experimental;

1995
Modelling cortical cataractogenesis 17: in vitro effect of a-lipoic acid on glucose-induced lens membrane damage, a model of diabetic cataractogenesis.
    Biochemistry and molecular biology international, 1995, Volume: 37, Issue:2

    Topics: Animals; Cataract; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Glucose; In Vitr

1995
alpha-Lipoic acid corrects neuropeptide deficits in diabetic rats via induction of trophic support.
    Neuroscience letters, 1997, Feb-07, Volume: 222, Issue:3

    Topics: Animals; Diabetes Mellitus, Experimental; Male; Nerve Growth Factors; Neuropeptide Y; Neuropeptides;

1997
Lipoic acid reduces glycemia and increases muscle GLUT4 content in streptozotocin-diabetic rats.
    Metabolism: clinical and experimental, 1997, Volume: 46, Issue:7

    Topics: Animals; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Experimental; Glucose Transporter Type 4; I

1997
Effects of alpha-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids.
    Diabetologia, 1998, Volume: 41, Issue:4

    Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Neuropathies; gamma-L

1998
A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy.
    Diabetologia, 1998, Volume: 41, Issue:7

    Topics: Animals; Antioxidants; Butylated Hydroxytoluene; Diabetes Mellitus, Experimental; Diabetic Neuropath

1998
Metabolic effects of thioctic acid in rodent models of insulin resistance and diabetes.
    Clinical and experimental pharmacology & physiology, 1998, Volume: 25, Issue:9

    Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Disease Models, Animal; Fructose; Glucose; H

1998
Diabetes-induced changes in lens antioxidant status, glucose utilization and energy metabolism: effect of DL-alpha-lipoic acid.
    Diabetologia, 1998, Volume: 41, Issue:12

    Topics: Adenine Nucleotides; Animals; Antioxidants; Diabetes Mellitus, Experimental; Energy Metabolism; Fruc

1998
Lipoic acid prevention of neural tube defects in offspring of rats with streptozocin-induced diabetes.
    American journal of obstetrics and gynecology, 1999, Volume: 180, Issue:1 Pt 1

    Topics: Animals; Diabetes Mellitus, Experimental; Female; Neural Tube Defects; Placenta; Pregnancy; Pregnanc

1999
Effects of diabetes and treatment with the antioxidant alpha-lipoic acid on endothelial and neurogenic responses of corpus cavernosum in rats.
    Diabetologia, 1999, Volume: 42, Issue:3

    Topics: Acetylcholine; Animals; Antioxidants; Atropine; Blood Glucose; Body Weight; Diabetes Mellitus, Exper

1999
Lipoic acid acutely induces hypoglycemia in fasting nondiabetic and diabetic rats.
    Metabolism: clinical and experimental, 1999, Volume: 48, Issue:4

    Topics: 3-Hydroxybutyric Acid; Alanine; Animals; Blood Glucose; Carnitine; Diabetes Mellitus, Experimental;

1999
Nerve conduction impairment in experimental diabetes-proximodistal gradient of severity.
    Muscle & nerve, 1999, Volume: 22, Issue:10

    Topics: Animals; Diabetes Mellitus, Experimental; Drug Combinations; Enzyme Inhibitors; gamma-Linolenic Acid

1999
Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy.
    Diabetes, 1999, Volume: 48, Issue:10

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relati

1999
Effect of alpha-lipoic acid supplementation on oxidative protein damage in the streptozotocin-diabetic rat.
    Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 2000, Volume: 199, Issue:4

    Topics: Analysis of Variance; Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Free Radical

2000
Early changes in lipid peroxidation and antioxidative defense in diabetic rat retina: effect of DL-alpha-lipoic acid.
    European journal of pharmacology, 2000, Jun-09, Volume: 398, Issue:1

    Topics: Animals; Antioxidants; Body Weight; Diabetes Mellitus, Experimental; Glucose; Glutathione; Glutathio

2000
Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy.
    Diabetes, 2000, Volume: 49, Issue:6

    Topics: Animals; Body Weight; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Energy Metabolism; Enz

2000
Effects of dietary supplementation of alpha-lipoic acid on early glomerular injury in diabetes mellitus.
    Journal of the American Society of Nephrology : JASN, 2001, Volume: 12, Issue:1

    Topics: Animals; Antioxidants; Collagen; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dietary Su

2001
The effect of gamma-linolenic acid-alpha-lipoic acid on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats.
    Journal of the neurological sciences, 2001, Jan-01, Volume: 182, Issue:2

    Topics: Animals; Blood Glucose; Body Weight; Brain; Central Nervous System; Diabetes Mellitus, Experimental;

2001
Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes.
    Diabetes, nutrition & metabolism, 2000, Volume: 13, Issue:6

    Topics: Animals; Antioxidants; Aorta; Blood Pressure; Carbohydrate Metabolism; Diabetes Mellitus, Experiment

2000
Metabolic effects of gamma-linolenic acid-alpha-lipoic acid conjugate in streptozotocin diabetic rats.
    Antioxidants & redox signaling, 1999,Winter, Volume: 1, Issue:4

    Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Electrophoresis, Polyacrylami

1999
Diabetes-induced changes in retinal NAD-redox status: pharmacological modulation and implications for pathogenesis of diabetic retinopathy.
    Pharmacology, 2001, Volume: 62, Issue:3

    Topics: Adrenergic alpha-Antagonists; Ammonia; Animals; Antioxidants; Cell Fractionation; Diabetes Mellitus,

2001
Oxidative stress participates in the breakdown of neuronal phenotype in experimental diabetic neuropathy.
    Diabetologia, 2001, Volume: 44, Issue:4

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; gamma-Linolenic Acid; Male; Nerve G

2001
Glutathione and alpha-lipoate in diabetic rats: nerve function, blood flow and oxidative state.
    European journal of clinical investigation, 2001, Volume: 31, Issue:5

    Topics: Animals; Antioxidants; Blood Flow Velocity; Diabetes Mellitus, Experimental; Diabetic Neuropathies;

2001
Effect of alpha-lipoic acid on vascular responses and nociception in diabetic rats.
    Free radical biology & medicine, 2001, Jul-01, Volume: 31, Issue:1

    Topics: Animals; Antioxidants; Blood Flow Velocity; Diabetes Mellitus, Experimental; Endothelium, Vascular;

2001
Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.
    Diabetes, 2001, Volume: 50, Issue:8

    Topics: Animals; Antioxidants; Aorta; Arterioles; Diabetes Mellitus, Experimental; Dietary Supplements; Inos

2001
The effects of treatment with alpha-lipoic acid or evening primrose oil on vascular hemostatic and lipid risk factors, blood flow, and peripheral nerve conduction in the streptozotocin-diabetic rat.
    Metabolism: clinical and experimental, 2001, Volume: 50, Issue:8

    Topics: Animals; Blood Circulation; Cholesterol; Diabetes Mellitus, Experimental; Fatty Acids, Essential; ga

2001
Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats.
    Diabetologia, 2001, Volume: 44, Issue:9

    Topics: Alternative Splicing; Animals; Antioxidants; Ascorbic Acid; Blood Glucose; Dehydroascorbic Acid; Dia

2001
Alpha-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes.
    Journal of the American Society of Nephrology : JASN, 2002, Volume: 13, Issue:1

    Topics: Albuminuria; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephrop

2002
Neuronal death in the rat hippocampus in experimental diabetes and cerebral ischaemia treated with antioxidants.
    Folia neuropathologica, 2001, Volume: 39, Issue:3

    Topics: Animals; Antioxidants; Apoptosis; Blood Glucose; Brain Ischemia; Caspase 3; Caspases; Cell Count; Co

2001
Elimination of *O(2)(-)/H(2)O(2) by alpha-lipoic acid mediates the recovery of basal EDRF/NO availability and the reversal of superoxide dismutase-induced relaxation in diabetic rat aorta.
    Diabetes, obesity & metabolism, 2002, Volume: 4, Issue:1

    Topics: Amitrole; Animals; Aorta, Thoracic; Blood Glucose; Body Weight; Catalase; Diabetes Mellitus, Experim

2002
Effect of alpha-lipoic acid on lipid peroxidation and anti-oxidant enzyme activities in diabetic rats.
    Clinical and experimental pharmacology & physiology, 2002, Volume: 29, Issue:4

    Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Enzyme Activation; Glutathione Peroxidase; G

2002
Effect of DL-alpha-lipoic acid on the citrate concentration and phosphofructokinase activity of perfused hearts from normal and diabetic rats.
    Biochemical and biophysical research communications, 1970, Nov-09, Volume: 41, Issue:3

    Topics: Animals; Caprylates; Citrates; Coenzyme A; Diabetes Mellitus, Experimental; Glucose; Glycogen; Heart

1970